In the US, two major regions supply the largest growth of innovation in the biotechnology and medical technology sector, Silicon Valley (SV) and Cambridge, Massachusetts. As a result, investors have always made a footprint in these areas. This action has benefited many sides: the investors, the innovators, and all the employees providing service to the industry. The influx of cash has catalysed numerous innovations from an idea to a complete product. Furthermore, this has provided thousands of jobs for scientists, engineers, and staff, not only in these regions, but all over the world. In return, this has rewarded many of the investors financially, but also the patients who have benefited dramatically through the advanced technologies.